The use of SGLT2 vs DPP4 inhibitors was linked to reduced cardiovascular and renal risks among patients with comorbid SLE and T2D.

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

SGLT2 inhibitors plus finerenone may have a protective effect against cardiovascular events in patients with HFpEF or HFmrEF.

NEW ORLEANS -- Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic ...

Winters can be uncomfortable for many people, but they can prove life-threatening for those with hypertension if they don't ...

An estimated 80 million people above the age of 18 years have diabetes in India, in addition to 25 million 2 that are pre-diabetic.

More work is needed to understand how to act preemptively on elevated heart failure risk, one researcher says.

Adverse effects of nicotine-replacement therapy are relatively minor (such as mouth and throat soreness) compared to smoking ...

DEAR DR. ROACH: I have a good friend who is almost 77 years old. He was a heavy smoker until about 14 years ago. He decided ...